A randomized controlled clinical trial of vildagliptin plus metformin combination therapy in patients with type II diabetes mellitus

por SU, YONG, SU, YA-LI, LV, LI-FANG, WANG, LI-MIN, LI, QUAN-ZHONG, ZHAO, ZHI-GANG
Publicado 2014

Randomized controlled clinical trial of a combination therapy of vildagliptin plus an α-glucosidase inhibitor for patients with type II diabetes mellitus

por SU, YONG, SU, YA-LI, LV, LI-FANG, WANG, LI-MIN, LI, QUAN-ZHONG, ZHAO, ZHI-GANG
Publicado 2014

Endocytosis of Peptidase Inhibitor SerpinE2 promotes Myocardial Fibrosis through activating ERK1/2 and β-catenin Signaling Pathways

por Li, Chao, Lv, Li-fang, Qi-Li, Mu-ge, Yang, Rui, Wang, Yu-jing, Chen, Shuang-shuang, Zhang, Ming-xiu, Li, Tian-yu, Yu, Tong, Zhou, Yu-hong, Liang, Hai-hai, Shan, Hong-li, Li, Xue-lian
Publicado 2022